Celularity Financial Health

Short Term Liabilities: CELU's short term assets ($63.1M) do not cover its short term liabilities ($69.2M).

Long Term Liabilities: CELU's short term assets ($63.1M) do not cover its long term liabilities ($203.7M).

Debt Level: CELU has more cash than its total debt.

Reducing Debt: Insufficient data to determine if CELU's debt to equity ratio has reduced over the past 5 years.

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CELU has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: CELU has less than a year of cash runway if free cash flow continues to reduce at historical rates of 18.6% each year

• Healthy companies in the Pharmaceuticals & Biotech industry.